Protective agent, erdosteine, against cisplatin-induced hepatic oxidant injury in rats
β Scribed by Ahmet Koc; Mehmet Duru; Harun Ciralik; Ramazan Akcan; Sadik Sogut
- Publisher
- Springer
- Year
- 2005
- Tongue
- English
- Weight
- 288 KB
- Volume
- 278
- Category
- Article
- ISSN
- 0300-8177
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The usefulness of doxorubicin (DXR) is limited by its cardiotoxicity. In order to improve future DXR therapy by using a new antioxidant agent, an experimental study was designed. This study was undertaken to determine whether DXRβinduced cardiotoxicity is prevented by erdosteine, a muco
Key words: nephrotoxicity; cisplatin; radical scavengers; methimazole; rat In adult rats 6 mg kg -1 body wt. cisplatin given i.p. was nephrotoxic. Four days of i.p. treatment with 40 mg kg -1 body wt. methimazole, which started 1 day before CP, prevented increases in blood urea nitrogen and in the r
In many patients treated with cisplatin a peripheral sensory neuropathy develops. This side-effect is considered dose-limiting, and therefore restricts the total dose of cisplatin that can be administered. Recent in vitro and in vivo studies suggest that recombinant human Glial Growth Factor 2 (rhGG